tiprankstipranks
Trending News
More News >
Scandinavian ChemoTech AB Class B (DE:8V6)
FRANKFURT:8V6
Germany Market

Scandinavian ChemoTech AB Class B (8V6) Income Statement

Compare
0 Followers

Scandinavian ChemoTech AB Class B Income Statement

Last quarter (Q4 2024), Scandinavian ChemoTech AB Class B's total revenue was kr2.04M, an increase of 302.56% from the same quarter last year. In Q4, Scandinavian ChemoTech AB Class B's net income was kr-3.17M. See Scandinavian ChemoTech AB Class B’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 6.57Mkr 2.82Mkr 473.00Kkr 49.00Kkr 131.00K
Gross Profit
kr 4.78Mkr 1.66Mkr -55.00Kkr 323.00Kkr -14.00K
Operating Expenses
kr 17.57Mkr 21.89Mkr 20.86Mkr 17.40Mkr 10.81M
Depreciation and Amortization
kr 2.06Mkr 109.00Kkr 41.00Kkr 42.00Kkr 56.00K
EBITDA
kr -10.73Mkr -19.58Mkr -20.81Mkr -17.03Mkr -10.77M
Operating Income
kr -12.80Mkr -20.24Mkr -20.91Mkr -17.08Mkr -10.83M
Other Income/Expenses
kr -921.00Kkr -854.00Kkr -1.83Mkr -666.00Kkr -835.00K
Pretax Income
kr -13.72Mkr -21.09Mkr -22.75Mkr -17.74Mkr -11.66M
Net Income
kr -13.72Mkr -21.09Mkr -24.58Mkr -18.42Mkr -12.50M
Per Share Metrics
Basic EPS
kr -0.66kr -1.50kr -2.47kr -2.13kr -2.54
Diluted EPS
kr -0.66kr -1.50kr -2.47kr -2.13kr -2.54
Weighted Average Shares Outstanding
20.66M 14.04M 9.97M 8.66M 4.92M
Weighted Average Shares Outstanding (Diluted)
20.66M 14.04M 9.97M 8.66M 4.92M
Currency in SEK

Scandinavian ChemoTech AB Class B Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis